[vc_row][vc_column][vc_column_text]
1919: Practice set up in Mumbai by Dr. C.N. Shroff on his return from London after qualifying in Ophthalmology Dr. Shroff founded the Ramwadi Free Eye Hospital to serve the underprivileged in Mumbai
1929: Dr C N Shroff was elected Secretary of the All India Ophthalmologist’s society, and served as its President in 1951
1961: Dr. Ashok C. Shroff joined the practice after his MS in Ophthalmology and his experience at the Moorfields Eye Hospital and the Institute of Ophthalmology
1962: Dr. Ashok C Shroff was one of the ophthalmologists in the country to perform modern retinal surgeries with the use of implants
1968: Cryosurgery for retinal detachment and cataract was performed
1970: Shroff Eye Clinic set up in 1973. Introduction of a number of new techniques in eye care – Fundus Fluorescein Angiography, Xenon arc photocoagulation, the precursor of the argon laser, microscopic cataract surgery & vitrectomy
1981: Dr. C. N. Shroff retires after a highly productive and meaningful career spanning 62 years
1983: Argon Laser, Krypton Laser, Phacoemulsification and A Scan sonography was introduced using the latest technology of the times
1990: Dr. Ashok C. Shroff honoured with National Award, the “Padma Shree” in recognition of his contribution to the ophthalmic profession
1997: Dr. Rahul Shroff and Dr. Anand Shroff join the practice
1997: Shroff Eye introduces advanced retina eye care
2001: Shroff Eye is awarded the ISO 9002 certification
2003: Shroff Eye opens its new hospital premises at Bandra (W), Mumbai as Shroff Eye Hospital
2004: Shroff Eye starts its in house LASIK centre
2006: Shroff Eye accredited by JCI (Joint Commission International, USA)
2007: Shroff Eye launches the Wavelight 500Hz Concerto, fastest and most advance technology in the world and only one in India
2007: Shroff Eye is the first eye hospital in Mumbai to use the treatment of C3R or Corneal Collagen Cross Linking for keratoconus, a corneal abnormality.
2009: Shroff Eye re- accredited by JCI (Joint Commission International, USA).
2010: Shroff Eye launches the Shroff Eye Bank and introduces Keratoplasty by the DSEK technique
2011: Dr Anand Shroff completes 100 Crystalens (R) accommodative implants for cataract surgery, being the second eye surgeon in India to cross this milestone.
2012: Shroff Eye re- accredited by JCI (Joint Commission International, USA).
Dr. Ashok C. Shroff Eye Specialist in Cataract and Medical Retinal conditions, started practice in 1961. |
Dr. Rahul Ashok Shroff Eye Specialist in diseases of Retina and Vitreous since 1996. |
Dr. Anand Ashok Shroff Eye Specialist in LASIK, Cataract and Glaucoma since 1996. |
Dr. Vishal Shah Eye Specialist in Diseases of the Cornea since 2009. |
Best Eye Hospital in India !
2012:
– Joint Commission international re accreditation.
2009:
– Joint Commission international re accreditation.
2007:
– First Eye Hospital in Mumbai to use C3R or Corneal Collagen Cross Linking for keratoconus.
2006:
– First Eye Hospital in India to be accredited by Joint Commission International, (USA) for excellence in patient care and healthcare Delivery
. – First Eye Hospital in India to use the World’s fastest laser – The Wavelight Concerto 500 Hz – (one of only 10 in the world) to remove spectacle numbers.
2001:
– Shroff Eye is awarded ISO 9001:2000 certification. It was the First Eye Hospital to get this certification in entire Western India.
1983:
– Phacoemulsification cataract surgery.
– Laser Photocoagulation.
1982: – Posterior chamber lens implant.
1974:
– Photocoagulation by portable Xenon machine.
1970:
– Angiography for retina.
– Assisted in making of fluorescein dye injections for retinal angiography.
1968:
– Cryo-extraction of cataract.
– Cryo-surgery for retinal detachment.
– Prophylactic treatment for retinal hole.
– Silicon implant with cryopexy for retinal detachment.
1957:
– DCR with electronic drill.
Cornea is the transparent front surface of the eye. Normally, when looking straight on at the eye, you look right through the cornea and see the coloured iris and black pupil of the eye. The cornea is avascular i.e. contains no blood vessels to nourish or protect it against infection, unlike other tissues in the body. Instead, it receives its nourishment from the tears and aqueous humour which is present in the anterior chamber. It is mainly composed of cells and proteins.
There are a lot of corneal disorders and diseases seen in routine practice. Enumerating below are a few of the common ones:
Dry eye can be caused due to any of the following reasons:
In people with dry eye, the eye produces fewer or less quality tears and is unable to keep its surface lubricated and comfortable. As we age, the eyes usually produce fewer tears. Also, in some cases, the lipid and mucin layers produced by the eye are of such poor quality that tears cannot remain in the eye long enough to keep the eye sufficiently lubricated.The main symptom of dry eye is usually a scratchy or foreign body or sandy feeling as if something is in the eye. Other symptoms may include stinging, irritation, itching, burning or nonspecific ocular discomfort of the eye; episodes of excess tearing that follow periods of very dry sensation; a stringy discharge from the eye; and pain and redness of the eye. Sometimes people with dry eye experience heaviness of the eyelids or blurred, changing, or decreased vision, although loss of vision is uncommon.
Dry eye is more common in women, especially after menopause. Surprisingly, some people with dry eye may have tears that run down their cheeks. This is because the eye may be producing less of the lipid and mucin layers of the tear film, which help keep tears in the eye. When this happens, tears do not stay in the eye long enough to thoroughly moisten it.
Dry eye can occur in climates with dry air, as well as with the use of some drugs, including antihistamines, nasal decongestants, tranquilizers, and anti-depressant drugs. People with dry eye should let their health care providers know all the medications they are taking, since some of them may intensify dry eye symptoms. People with connective tissue diseases, such as rheumatoid arthritis, can also develop dry eye. It is important to note that dry eye is sometimes a symptom of Sjogren’s syndrome, a disease that attacks the body’s lubricating glands, such as the tear and salivary glands. A complete physical examination may diagnose any underlying diseases.
Artificial tears, which lubricate the eye, are the principal treatment for dry eye. They are available over-the-counter as eye drops. Sterile ointme
Corneal dystrophies affect vision in widely differing ways. Some cause severe visual impairment, while a few cause no vision problems and are discovered during a routine eye examination. Other dystrophies may cause repeated episodes of pain without leading to permanent loss of vision. The dystrophies are classified according to the anatomic site involved:
Epithelial dystrophies: Epithelial basement membrane dystrophy, Reis Buckler’s dystrophy, Meesman’s dystrophy
Stromal dystrophies: Granular dystrophy, Macular dystrophy, Lattice dystrophy, Schnyder’s crystalline dystrophy
Endothelial dystrophies: Fuch’s endothelial dystrophy, Posterior polymorphous dystrophy, Congenital Hereditary endothelial dystrophy.
Some of these dystrophies do not cause a lot of visual impairment. However most of them require surgery in the form of corneal transplantation for visual
restoration.
Keratoconus is characterized by progressive thinning and ectasia which results in deterioration of the quality of vision and also the quality of life. As the disease begins in young adults, it affects the most productive years of life. So far there has been no effective way to stop the progression of keratoconus. Current methods such as rigid contact lens, & intracorneal ring segments only the refractive error can be corrected without any effect on the progression of keratoconus. It is estimated that eventually 21% of the keratoconus patients require surgical intervention to restore corneal anatomy and eyesight. A new modality of treatment, based on collagen crosslinking with the help of Ultraviolet A (UVA, 365nm) and the photosensitizer riboflavin phosphate has been described which changes the intrinsic biomechanical properties of the cornea, increasing its strength by almost 300%. This increase in corneal strength has shown to arrest the progression of keratoconus in numerous studies all over the world.
Topography guided C3R (Crosslinking) with Topolink
This is done only if you are in early stages and if fit for the same as examined by our doctors as we can additionally also smoothen the shape of the cornea with our laser (PRK), besides strengthening it (C3R).
Accelerated C3R or KXL
The accelerated crosslinking mirrors the traditional crosslinking procedure but differs and benefits patients in 3 ways:
3. Red eye – there are multitude causes of a red eye in contact lens users. Broadly, they are either infective or noninfective. Amongst the infective causes it can be either conjunctivitis or keratitis. The noninfective causes include: corneal hypoxia, damaged lenses, incomplete blinking, deposits on the lens, poorly fitting lenses and reactions to the lens cleaning solutions. There could be associated, non-contact lens related causes of red eye viz., blepharitis or meibommianitis.
4. Corneal problems related to contact lens wear include: corneal abrasions, punctuate keratitis, sterile corneal infiltrates, superior limbic keratoconjunctivitis, neovascularisation and corneal ulcer.
5. Giant papillary conjunctivitis: marked by increasing lens awareness, itching, mucous discharge, formation of a coating on the contact lens and development of papillae
.
Treatment includes topical dehydrating agents, intra-ocular pressure lowering agents, lubricating agents, bandage soft contact lenses for mild to moderate cases and treatment of any secondary microbial infection. For severe cases, corneal transplantation is usually required.
Till recently, full thickness corneal transplantation was the treatment of choice for these cases. The surgical treatment of corneal endothelial dysfunction has been revolutionized with Descemet’s stripping with endothelial keratoplasty (DSEK). As an alternative to traditional penetrating keratoplasty (PK), DSEK has gained popularity because the selective transplantation of the endothelial layer avoids the potential complications of PK such as wound dehiscence, wound infections, and high postoperative astigmatism. Originally conceived as posterior lamellar keratoplasty by Melles et al, selective endothelial keratoplasty has evolved into deep lamellar with endothelial keratoplasty and now Descemet’s stripping with endothelial keratoplasty (DSEK). In DSEK the recipient Descemet’s membrane and endothelium are stripped and a posterior lamellar graft, or DSEK graft, then is inserted and allowed to unfold with subsequent recipient-to-donor stromal adherence. Adhesion of the DSEK graft allows for eventual deturgescence of the recipient cornea as the donor endothelial cells begin their pump action. Preparation of the posterior lamellar graft, containing the donor posterior stroma, Descemet’s membrane, and endothelium, has been simplified by use of a microkeratome on a corneoscleral button mounted on an artificial chamber. This variant in procedure has been termed Descemet’s stripping automated endothelial keratoplasty (DSAEK).
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_message style=”square” message_box_color=”mulled_wine”]For more information, medical assessment and medical quote send your detailed medical history and medical reports as email attachment to Email : – info@wecareindia.com Call: +91 9029304141 (10 am. To 8 pm. IST)[/vc_message][/vc_column][/vc_row]